OptumInsight’s evidence lifecycle supports product development from strategy through stakeholder engagement

OptumInsight’s life sciences group addresses the changing global economic and regulatory competitive landscape by assisting life sciences clients to identify, analyze, and measure the value of their products. We seek to optimize the commercialization of product offerings by working across both R&D and brand/marketing so that our clients are able to realize optimal market access, authorization, and positioning. We do this by utilizing unique and extensive real-world data assets, cutting-edge research design and analytics, and deep experience and knowledge of the global life sciences industry and its markets.

We help our clients by developing market access and product value strategies, by conducting late phase and health economics and outcomes research, and by providing global strategic regulatory and risk management services. Finally, we address and help manage the process of transitioning products from R&D to marketing to minimize value destruction. Specifically, the products and services we provide include health economics and outcomes research; late phase and Phase IV research; market access, pricing, and reimbursement services; data and informatics services; epidemiology and risk management solutions; drug safety and pharmacovigilance services; regulatory consulting services; and products and services related to patient-reported outcomes.